The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/103827 https://doi.org/10.1016/j.celrep.2021.109864 |
Resumo: | Increasing evidence suggests that neurodevelopmental alterations might contribute to increase the susceptibility to develop neurodegenerative diseases. We investigate the occurrence of developmental abnormalities in dopaminergic neurons in a model of Parkinson's disease (PD). We monitor the differentiation of human patient-specific neuroepithelial stem cells (NESCs) into dopaminergic neurons. Using high-throughput image analyses and single-cell RNA sequencing, we observe that the PD-associated LRRK2-G2019S mutation alters the initial phase of neuronal differentiation by accelerating cell-cycle exit with a concomitant increase in cell death. We identify the NESC-specific core regulatory circuit and a molecular mechanism underlying the observed phenotypes. The expression of NR2F1, a key transcription factor involved in neurogenesis, decreases in LRRK2-G2019S NESCs, neurons, and midbrain organoids compared to controls. We also observe accelerated dopaminergic differentiation in vivo in NR2F1-deficient mouse embryos. This suggests a pathogenic mechanism involving the LRRK2-G2019S mutation, where the dynamics of dopaminergic differentiation are modified via NR2F1. |
id |
RCAP_a53036f6809e0dbac137d895a5f5b301 |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/103827 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1dopaminergic neuronsLRRK2NR2F1Parkinson's diseaseAnimalsBrainCOUP Transcription Factor ICell CycleCell LineCell ProliferationCell SurvivalDopaminergic NeuronsFemaleHumansInduced Pluripotent Stem CellsLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MaleMice, 129 StrainMice, KnockoutMutationNeural Stem CellsParkinson DiseasePhenotypeRNA-SeqSignal TransductionSingle-Cell AnalysisTime FactorsNeurogenesisIncreasing evidence suggests that neurodevelopmental alterations might contribute to increase the susceptibility to develop neurodegenerative diseases. We investigate the occurrence of developmental abnormalities in dopaminergic neurons in a model of Parkinson's disease (PD). We monitor the differentiation of human patient-specific neuroepithelial stem cells (NESCs) into dopaminergic neurons. Using high-throughput image analyses and single-cell RNA sequencing, we observe that the PD-associated LRRK2-G2019S mutation alters the initial phase of neuronal differentiation by accelerating cell-cycle exit with a concomitant increase in cell death. We identify the NESC-specific core regulatory circuit and a molecular mechanism underlying the observed phenotypes. The expression of NR2F1, a key transcription factor involved in neurogenesis, decreases in LRRK2-G2019S NESCs, neurons, and midbrain organoids compared to controls. We also observe accelerated dopaminergic differentiation in vivo in NR2F1-deficient mouse embryos. This suggests a pathogenic mechanism involving the LRRK2-G2019S mutation, where the dynamics of dopaminergic differentiation are modified via NR2F1.Elsevier2021-10-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/103827http://hdl.handle.net/10316/103827https://doi.org/10.1016/j.celrep.2021.109864eng22111247Walter, JonasBolognin, SilviaPoovathingal, Suresh K.Magni, StefanoGérard, DeborahAntony, Paul M. A.Nickels, Sarah L.Salamanca, LuisBerger, EmanuelSmits, Lisa M.Grzyb, KamilPerfeito, RitaHoel, FredrikQing, XiaobingOhnmacht, JochenBertacchi, MicheleJarazo, JavierIgnac, TomaszMonzel, Anna S.Gonzalez-Cano, LauraKrüger, RejkoSauter, ThomasStuder, MichèleAlmeida, Luís Pereira deTronstad, Karl J.Sinkkonen, LasseSkupin, AlexanderSchwamborn, Jens C.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-11-30T21:38:29Zoai:estudogeral.uc.pt:10316/103827Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:20:35.937507Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1 |
title |
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1 |
spellingShingle |
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1 Walter, Jonas dopaminergic neurons LRRK2 NR2F1 Parkinson's disease Animals Brain COUP Transcription Factor I Cell Cycle Cell Line Cell Proliferation Cell Survival Dopaminergic Neurons Female Humans Induced Pluripotent Stem Cells Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Male Mice, 129 Strain Mice, Knockout Mutation Neural Stem Cells Parkinson Disease Phenotype RNA-Seq Signal Transduction Single-Cell Analysis Time Factors Neurogenesis |
title_short |
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1 |
title_full |
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1 |
title_fullStr |
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1 |
title_full_unstemmed |
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1 |
title_sort |
The Parkinson's-disease-associated mutation LRRK2-G2019S alters dopaminergic differentiation dynamics via NR2F1 |
author |
Walter, Jonas |
author_facet |
Walter, Jonas Bolognin, Silvia Poovathingal, Suresh K. Magni, Stefano Gérard, Deborah Antony, Paul M. A. Nickels, Sarah L. Salamanca, Luis Berger, Emanuel Smits, Lisa M. Grzyb, Kamil Perfeito, Rita Hoel, Fredrik Qing, Xiaobing Ohnmacht, Jochen Bertacchi, Michele Jarazo, Javier Ignac, Tomasz Monzel, Anna S. Gonzalez-Cano, Laura Krüger, Rejko Sauter, Thomas Studer, Michèle Almeida, Luís Pereira de Tronstad, Karl J. Sinkkonen, Lasse Skupin, Alexander Schwamborn, Jens C. |
author_role |
author |
author2 |
Bolognin, Silvia Poovathingal, Suresh K. Magni, Stefano Gérard, Deborah Antony, Paul M. A. Nickels, Sarah L. Salamanca, Luis Berger, Emanuel Smits, Lisa M. Grzyb, Kamil Perfeito, Rita Hoel, Fredrik Qing, Xiaobing Ohnmacht, Jochen Bertacchi, Michele Jarazo, Javier Ignac, Tomasz Monzel, Anna S. Gonzalez-Cano, Laura Krüger, Rejko Sauter, Thomas Studer, Michèle Almeida, Luís Pereira de Tronstad, Karl J. Sinkkonen, Lasse Skupin, Alexander Schwamborn, Jens C. |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Walter, Jonas Bolognin, Silvia Poovathingal, Suresh K. Magni, Stefano Gérard, Deborah Antony, Paul M. A. Nickels, Sarah L. Salamanca, Luis Berger, Emanuel Smits, Lisa M. Grzyb, Kamil Perfeito, Rita Hoel, Fredrik Qing, Xiaobing Ohnmacht, Jochen Bertacchi, Michele Jarazo, Javier Ignac, Tomasz Monzel, Anna S. Gonzalez-Cano, Laura Krüger, Rejko Sauter, Thomas Studer, Michèle Almeida, Luís Pereira de Tronstad, Karl J. Sinkkonen, Lasse Skupin, Alexander Schwamborn, Jens C. |
dc.subject.por.fl_str_mv |
dopaminergic neurons LRRK2 NR2F1 Parkinson's disease Animals Brain COUP Transcription Factor I Cell Cycle Cell Line Cell Proliferation Cell Survival Dopaminergic Neurons Female Humans Induced Pluripotent Stem Cells Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Male Mice, 129 Strain Mice, Knockout Mutation Neural Stem Cells Parkinson Disease Phenotype RNA-Seq Signal Transduction Single-Cell Analysis Time Factors Neurogenesis |
topic |
dopaminergic neurons LRRK2 NR2F1 Parkinson's disease Animals Brain COUP Transcription Factor I Cell Cycle Cell Line Cell Proliferation Cell Survival Dopaminergic Neurons Female Humans Induced Pluripotent Stem Cells Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Male Mice, 129 Strain Mice, Knockout Mutation Neural Stem Cells Parkinson Disease Phenotype RNA-Seq Signal Transduction Single-Cell Analysis Time Factors Neurogenesis |
description |
Increasing evidence suggests that neurodevelopmental alterations might contribute to increase the susceptibility to develop neurodegenerative diseases. We investigate the occurrence of developmental abnormalities in dopaminergic neurons in a model of Parkinson's disease (PD). We monitor the differentiation of human patient-specific neuroepithelial stem cells (NESCs) into dopaminergic neurons. Using high-throughput image analyses and single-cell RNA sequencing, we observe that the PD-associated LRRK2-G2019S mutation alters the initial phase of neuronal differentiation by accelerating cell-cycle exit with a concomitant increase in cell death. We identify the NESC-specific core regulatory circuit and a molecular mechanism underlying the observed phenotypes. The expression of NR2F1, a key transcription factor involved in neurogenesis, decreases in LRRK2-G2019S NESCs, neurons, and midbrain organoids compared to controls. We also observe accelerated dopaminergic differentiation in vivo in NR2F1-deficient mouse embryos. This suggests a pathogenic mechanism involving the LRRK2-G2019S mutation, where the dynamics of dopaminergic differentiation are modified via NR2F1. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-10-19 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/103827 http://hdl.handle.net/10316/103827 https://doi.org/10.1016/j.celrep.2021.109864 |
url |
http://hdl.handle.net/10316/103827 https://doi.org/10.1016/j.celrep.2021.109864 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
22111247 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134098370854912 |